- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Insipidus in Japan
Total 502 results
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusUnited States, Czechia, France, Spain, Japan, Germany, Italy, Brazil, Denmark, Austria, United Kingdom, China, Russian Federation, Mexico, Poland, Ukraine, Israel, Puerto Rico
-
TakedaCompletedType 2 Diabetes Mellitus and MicroalbuminuriaJapan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
TheracosCompletedType 2 Diabetes MellitusUnited States, France, Spain, Japan
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Korea, Republic of, Australia, India, Canada, Japan, South Africa
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, China, Japan, Argentina, Puerto Rico, Mexico
-
Eli Lilly and CompanyCompletedDiabetes | Type 1 DiabetesUnited States, Taiwan, Japan, Poland, Argentina, Slovakia, Puerto Rico
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusItaly, Japan, United States, Puerto Rico, Spain, Taiwan, Mexico, Austria, Germany, Poland, New Zealand, Romania, Russian Federation, Argentina, India, Sweden, Slovakia, Australia, Brazil, Greece
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Eli Lilly and CompanyCompletedDiabetes | Type 2 DiabetesUnited States, China, Germany, Mexico, Brazil, Canada, Japan, Korea, Republic of, Puerto Rico, Czechia, Greece
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Mexico, Japan, Serbia, Turkey, Italy, Czechia, Bulgaria, Algeria, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, United Kingdom, Mexico, Russian Federation, Japan, Canada, Italy, South Africa, Romania
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Hungary, India, Japan, Poland, Russian Federation
-
Boehringer IngelheimCompleted
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Spain, Taiwan, Japan, Poland, Argentina, Hungary, Puerto Rico, Korea, Republic of, Slovakia
-
Listen Trial GroupCompletedHypercholesterolemia With Concomitant Type 2 DiabetesJapan
-
Novo Nordisk A/SCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1India, Italy, United Kingdom, Finland, Japan, Argentina, Macedonia, The Former Yugoslav Republic of, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Japan, Puerto Rico, Serbia, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Puerto Rico, Canada, Hungary, Greece, Japan, Bulgaria, Slovakia, Ukraine, Czechia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, United States, Japan, Netherlands, Russian Federation, Bulgaria, United Kingdom, North Macedonia, South Africa, Italy, Finland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Croatia, Japan, Slovakia, Germany, Latvia, South Africa, Czechia, United Arab Emirates, Hungary, Ukraine, Puerto Rico
-
Eli Lilly and CompanyCompletedObesity | Overweight | Type 2 DiabetesUnited States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Japan, Puerto Rico, Canada, France, Mexico, Poland, Russian Federation, Greece
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Japan, Russian Federation, Spain, Sweden, Argentina, Hungary, Norway, South Africa, Turkey, Bulgaria, Romania, Thailand, Portugal, Hong Kong, Mexico, Ukraine, Czechia
-
AstraZenecaBristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States, Germany, Belgium, Canada, Japan, Chile, United Kingdom, Poland, Netherlands, Argentina, Sweden, Russian Federation, Switzerland
-
SanofiCompletedType 1 Diabetes MellitusJapan, Spain, Germany, United States, France, Hungary, Poland, Russian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, China, Taiwan, Canada, Switzerland, Japan, Brazil, Russian Federation, Hungary, Greece, France, Israel, Sweden, Slovakia
-
TheracosCompletedDiabetes Mellitus, Type 2United States, Japan
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 1Japan, United States, Greece, Belgium, Poland, Germany, Hungary, Mexico, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Israel, Italy, Japan, Russian Federation, Canada, Austria, Taiwan, Serbia, Germany, Bulgaria, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Israel, Japan, Russian Federation, United Kingdom, France, Mexico, South Africa, Turkey, Argentina, Germany, Romania, Brazil, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Israel, Japan, Mexico, Argentina, Turkey, Australia, Algeria, Saudi Arabia, Brazil, China
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes MellitusChina, United States, Netherlands, Spain, Australia, Austria, India, Canada, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Italy, Argentina, Brazil, Puerto Rico, Ukraine, Hungary, Czechia, Turkey, Korea, Republic... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Netherlands, Puerto Rico, Romania, Sweden
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, India, Italy, Mexico, Russian Federation, United Kingdom, Spain, Malaysia, Croatia, Greece, Korea, Republic of, Japan, South Africa, Algeria, Thailand, Argentina, Brazil, Canada, Romania